SCHEMBL4756579

SCHEMBL4756579

CS(=O)(=O)c1sc(NC(=O)c2cc(Br)cc(Br)c2O)nc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPD1 P10809 4/20 0.46
HSPE1 P61604 4/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
HTT P42858 2/20 0.45
ALDH1A1 P00352 1/20 0.45
EGFR P00533 1/20 0.45
LMNA P02545 1/20 0.45
ERBB2 P04626 1/20 0.45
CYP1A2 P05177 1/20 0.45
LCK P06239 1/20 0.45
MAPT P10636 1/20 0.45
CYP2C9 P11712 1/20 0.45
PTGS1 P23219 1/20 0.45
MAPK1 P28482 1/20 0.45
MAPK14 Q16539 1/20 0.45
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
KDR P35968 1/20 0.42
PNLIP P16233 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756962 0.84 NPC1 (0.40) MEN1KMT2AALDH1A1LCKMAPT
SCHEMBL4757167 0.81 RAB9A (0.43) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL10114372 0.80 KDM4E (0.38) MEN1KMT2AHTTALDH1A1LMNA
SCHEMBL4756728 0.77 MEN1 (0.47) HSPD1HSPE1MEN1KMT2AHTT
SCHEMBL4756535 0.76 RAB9A (0.57) MEN1KMT2AHTTALDH1A1LMNA
SCHEMBL10114558 0.76 RAB9A (0.39) MEN1KMT2AHTTALDH1A1LMNA
SCHEMBL4756873 0.74 NPC1 (0.43) MEN1KMT2ANPC1RAB9ARXFP1
SCHEMBL17433397 0.71 RAB9A (0.61) HSPD1HSPE1MEN1KMT2AHTT
SCHEMBL4757138 0.70 RAB9A (0.43) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL4757180 0.68 RAB9A (0.48) MEN1KMT2AALDH1A1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC HSPD1 313/4885HSPE1 342/4885MEN1 4564/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC HSPD1 313/4885HSPE1 342/4885MEN1 4564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.